The Future of Clinical Trials is Now
The Future of Clinical Trials Is Now
The COVID-19 pandemic has created numerous challenges for Sponsors worldwide, forcing clinical trials to adapt to changing conditions and innovate for the future simultaneously. Ancillare CEO Dr. Joanne Santomauro was interviewed on how proper supply plans are critical to overall trial success, and how data and technology can shape the future of Clinical Trial Ancillary Supply Chain (CTASC) management.
%
of Sponsors surveyed said they would benefit from a partner who provides end-to-end CTASC services.
%
of Sponsors said that a single point-of-contact — who manages CTASCs from start to finish — would be most helpful to their job.
Sponsors cite a lack of technology integration as their biggest clinical trial pain point.
"Ancillare has given my team a wealth of resources to optimize our Ancillary Supply Chain. They have become a true partner in our process."
— Vice President, Clinical Operations, Top 5 Pharma
Ancillare CEO Dr. Joanne Santomauro was interviewed by industry publication PharmaVOICE. Get her insights on how optimizing your Clinical Trial Ancillary Supply Chain leads to overall trial success. Please complete the form below to gain instant access.
